104 related articles for article (PubMed ID: 3607739)
21. Morphologic and biochemical variability of tissue and cultured cells from human pheochromocytoma.
Jaques S; Tobes MC
J Cell Physiol; 1986 Aug; 128(2):261-70. PubMed ID: 3733889
[TBL] [Abstract][Full Text] [Related]
22. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Lashford LS; Hancock JP; Kemshead JT
Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
[TBL] [Abstract][Full Text] [Related]
23. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
25. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
[TBL] [Abstract][Full Text] [Related]
26. Multipoint analysis of reduced (125)I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism.
Fukumitsu N; Suzuki M; Fukuda T; Kiyono Y
Nucl Med Biol; 2009 Aug; 36(6):623-9. PubMed ID: 19647168
[TBL] [Abstract][Full Text] [Related]
27. Platelet uptake of the pheochromocytoma-scanning agent 131I-meta-iodobenzylguanadine.
Feldman JM; Frankel N; Coleman RE
Metabolism; 1984 May; 33(5):397-9. PubMed ID: 6717272
[TBL] [Abstract][Full Text] [Related]
28. Effects of extrinsically elevated plasma norepinephrine concentration on myocardial 123I-MIBG kinetics in rats.
Shouda S; Kurata C; Mikami T; Wakabayashi Y
J Nucl Med; 1999 Dec; 40(12):2088-93. PubMed ID: 10616890
[TBL] [Abstract][Full Text] [Related]
29. HBO and the uptake and retention of [125I] MIBG in human platelets and two neuroendocrine cell lines.
Tytgat GA; Cornelissen J; Van den Brug M; Van Kuilenburg AB; Voute PA; Van der Kleij AJ; Van Gennip AH
Anticancer Res; 1997; 17(2A):1209-12. PubMed ID: 9137473
[TBL] [Abstract][Full Text] [Related]
30. Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
Kölby L; Bernhardt P; Johanson V; Wängberg B; Muth A; Jansson S; Forssell-Aronsson E; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():491-7. PubMed ID: 17102116
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
32. [125I]MIBG uptake and release in different regions of the rat brain.
Baulieu JL; Huguet F; Chalon S; Gerard P; Frangin Y; Besnard JC; Pourcelot L; Guilloteau D
Int J Rad Appl Instrum B; 1990; 17(5):511-4. PubMed ID: 2391247
[TBL] [Abstract][Full Text] [Related]
33. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function.
Slosman DO; Davidson D; Brill AB; Alderson PO
Eur J Nucl Med; 1988; 13(10):543-7. PubMed ID: 3371377
[TBL] [Abstract][Full Text] [Related]
34. Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studies.
Guilloteau D; Chalon S; Baulieu JL; Huguet F; Desplanches G; Chambon C; Vilar MP; Pourcelot L; Besnard JC
Eur J Nucl Med; 1988; 14(7-8):341-4. PubMed ID: 3141186
[TBL] [Abstract][Full Text] [Related]
35. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
Rutgers M; Tytgat GA; Verwijs-Janssen M; Buitenhuis C; Voûte PA; Smets LA
Int J Cancer; 1993 May; 54(2):290-5. PubMed ID: 8486431
[TBL] [Abstract][Full Text] [Related]
36. Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.
Kölby L; Bernhardt P; Levin-Jakobsen AM; Johanson V; Wängberg B; Ahlman H; Forssell-Aronsson E; Nilsson O
Br J Cancer; 2003 Oct; 89(7):1383-8. PubMed ID: 14520475
[TBL] [Abstract][Full Text] [Related]
37. Radiolabeled meta-iodobenzylguanidine and the adrenergic neurons of salivary glands.
Sisson JC; Wieland DM; Jaques S; Sherman P; Fisher S; Mallette S; Meyers L; Mangner TJ
Am J Physiol Imaging; 1987; 2(1):1-9. PubMed ID: 3451762
[TBL] [Abstract][Full Text] [Related]
38. Effects of anesthetic agents on cellular 123I-MIBG transport and in vivo 123I-MIBG biodistribution.
Ko BH; Paik JY; Jung KH; Bae JS; Lee EJ; Choe YS; Kim BT; Lee KH
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):554-61. PubMed ID: 17934728
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and regulation of 123I-MIBG transport in cultured pulmonary endothelial cells.
Lee KH; Ko BH; Paik JY; Jung KH; Bae JS; Choi JY; Choe YS; Kim BT
J Nucl Med; 2006 Mar; 47(3):437-42. PubMed ID: 16513613
[TBL] [Abstract][Full Text] [Related]
40. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R
Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]